On Monday, Vail Resorts, Inc. (NYSE:MTN)’s shares declined -4.07% to $103.05.
Vail Resorts, Inc. (MTN) declared that Susan Decker has been designated to the Company’s Board of Directors, effective right away.
Decker, who served as both president and chief financial officer at Yahoo! Inc., presently serves on several boards of directors, counting Berkshire Hathaway; Intel Corporation, where she is lead director; and Costco Wholesale. She also serves as an advisor for several venture-backed Internet start-ups and is a trustee of the global non-profit organization, Save the Children.
Vail Resorts, Inc., through its auxiliaries, operates mountain resorts and urban ski areas in the United States. The company operates in three segments: Mountain, Lodging, and Real Estate.
NetEase, Inc (ADR)(NASDAQ:NTES)’s shares gained 1.08% to $114.35.
NetEase, Inc. ( NTES) expanded its Western mobile game lineup with the release of a new puzzle game, Lunar Flowers, accessible now for iPhone, iPad and iPod touch.
Set in a magical land with gentle seas and stairways to heaven, players will assist a princess complete challenges and puzzles as she traverses across her moonlit dream world. With multiple levels to play and a wide variety of puzzle types, Lunar Flowers is as challenging as it is elegant. The game features a serene, single-swipe puzzle mechanic, a flowing traditional Chinese art style, and rich original musical score. Lunar Flowers is completely free to download at launch for a limited time and contains no in-app purchases or advertisements. After the promotional period ends, Lunar Flowers will be accessible for download for $0.99 USD on the App Store.
NetEase, Inc., through its auxiliaries, operates an interactive online community in the People’s Republic of China. The company operates in three segments: Online Game Services; Advertising Services; and E-mail, E-commerce and Others. It offers massively multi-player online role-playing games and mobile games; and distributes its point cards to gamers across China, in addition to through wholesalers, Internet cafés, software stores, supermarkets, bookstores, newspaper stands, and convenience stores primarily in Guangzhou Province, Shanghai, and Beijing.
At the end of Monday’s trade, Amyris Inc (NASDAQ:AMRS)‘s shares surged 7.29% to $2.06.
Amyris, Inc. (AMRS), the industrial bioscience company, recently declared a multi-year, Technology Investment Agreement (TIA) worth up to $35 million with the Defense Advanced Research Projects Agency’s (DARPA) Biological Technologies Office to create new research and development tools and technologies that will significantly reduce the time and cost of bringing new molecules to market. Amyris has chosen five specialized subcontractors to assist in achieving these innovations.
According to DARPA, its focus in working with industrial biotechnology companies is to competitively solicit “innovative proposals to develop new tools, technologies and methodologies” to create new capabilities in biotech. The tools and infrastructure developed through DARPA-funded efforts are predictable to enable the rapid and scalable development of transformative defense-relevant products and systems that are presently too complex to access.
Amyris, Inc. provides various alternatives to a range of petroleum-sourced products for the consumer care, specialty chemical, and transportation fuel markets worldwide. The company applies its industrial synthetic biology platform to design microbes and primarily yeast, in addition to convert plant-sourced sugars into renewable hydrocarbons.
IMS Health Holdings Inc (NYSE:IMS), ended its Monday’s trading session with -3.89% loss, and closed at $29.43.
The number of mobile health applications accessible to consumers now surpasses 165,000, as developers incorporate innovative data collection features linked to sensors and wearables, according to a new report released recently by the IMS Institute for Healthcare Informatics. While most accessible apps focus on overall wellness, healthcare systems and professionals are expressing greater interest and excitement in broader app use as barriers to mainstream adoption of mHealth are removed—especially in the area of chronic disease administration.
The IMS Institute study found that one in ten apps now has the capability to connect to a device or sensor, providing biofeedback and physiological function data from the patient and greatly extending the accuracy and convenience of data collection. Nearly a quarter of consumer apps are now focused on disease and treatment administration, while two-thirds target fitness and wellness. The number and variety of mHealth apps present an overwhelming set of options for consumers, resulting in 40 percent of apps having fewer than 5,000 downloads.
IMS Health Holdings, Inc. provides information and technology services to healthcare industry worldwide. Its principal products comprise national information offerings that provide performance metrics related to the sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity through multiple channels; and sub-national offerings, which offer information related to the measurement of sales at the regional, zip code, and individual prescriber level.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
